DECREASED MORTALITY WITH BETA-BLOCKER THERAPY IN PATIENTS WITH HFPEF INDUCED OR EXACERBATED BY ATRIAL FIBRILLATION

There are no proven effective treatments can reduce the mortality in heart failure with preserved ejection fraction (HFpEF), probably due to its heterogeneous nature which will weaken the effect of therapy in clinical studies. We evaluated the effect of beta-blockers treatment in patients with